BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36877259)

  • 1. Utility and Safety of Backup Insulin Regimens Generated by the Bionic Pancreas: A Randomized Study.
    Mauras N; Damiano ER; El-Khatib FH; Marak MC; Calhoun P; Ruedy KJ; Balliro C; Li Z; Beck RW; Russell SJ
    Diabetes Technol Ther; 2023 Jun; 25(6):437-441. PubMed ID: 36877259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
    El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
    Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial.
    Messer LH; Buckingham BA; Cogen F; Daniels M; Forlenza G; Jafri RZ; Mauras N; Muir A; Wadwa RP; White PC; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro CA; Li Z; Marak MC; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 Oct; 24(10):712-725. PubMed ID: 36173237
    [No Abstract]   [Full Text] [Related]  

  • 4. The Insulin-Only Bionic Pancreas Pivotal Trial Extension Study: A Multi-Center Single-Arm Evaluation of the Insulin-Only Configuration of the Bionic Pancreas in Adults and Youth with Type 1 Diabetes.
    Lynch J; Kanapka LG; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro C; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 Oct; 24(10):726-736. PubMed ID: 36173238
    [No Abstract]   [Full Text] [Related]  

  • 5. Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
    ; Russell SJ; Beck RW; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro CA; Li Z; Calhoun P; Wadwa RP; Buckingham B; Zhou K; Daniels M; Raskin P; White PC; Lynch J; Pettus J; Hirsch IB; Goland R; Buse JB; Kruger D; Mauras N; Muir A; McGill JB; Cogen F; Weissberg-Benchell J; Sherwood JS; Castellanos LE; Hillard MA; Tuffaha M; Putman MS; Sands MY; Forlenza G; Slover R; Messer LH; Cobry E; Shah VN; Polsky S; Lal R; Ekhlaspour L; Hughes MS; Basina M; Hatipoglu B; Olansky L; Bhangoo A; Forghani N; Kashmiri H; Sutton F; Choudhary A; Penn J; Jafri R; Rayas M; Escaname E; Kerr C; Favela-Prezas R; Boeder S; Trikudanathan S; Williams KM; Leibel N; Kirkman MS; Bergamo K; Klein KR; Dostou JM; Machineni S; Young LA; Diner JC; Bhan A; Jones JK; Benson M; Bird K; Englert K; Permuy J; Cossen K; Felner E; Salam M; Silverstein JM; Adamson S; Cedeno A; Meighan S; Dauber A
    N Engl J Med; 2022 Sep; 387(13):1161-1172. PubMed ID: 36170500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Multicenter Randomized Trial Evaluating the Insulin-Only Configuration of the Bionic Pancreas in Adults with Type 1 Diabetes.
    Kruger D; Kass A; Lonier J; Pettus J; Raskin P; Salam M; Trikudanathan S; Zhou K; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro C; Li Z; Marak MC; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 Oct; 24(10):697-711. PubMed ID: 36173236
    [No Abstract]   [Full Text] [Related]  

  • 8. Outpatient glycemic control with a bionic pancreas in type 1 diabetes.
    Russell SJ; El-Khatib FH; Sinha M; Magyar KL; McKeon K; Goergen LG; Balliro C; Hillard MA; Nathan DM; Damiano ER
    N Engl J Med; 2014 Jul; 371(4):313-325. PubMed ID: 24931572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes.
    Beck RW; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro C; Li Z; Calhoun P
    Diabetes Technol Ther; 2022 Oct; 24(10):681-696. PubMed ID: 36173235
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis- Related Diabetes.
    Sherwood JS; Castellanos LE; O'Connor MY; Balliro CA; Hillard MA; Gaston SG; Bartholomew R; Greaux E; Sabean A; Zheng H; Marchetti P; Uluer A; Sawicki GS; Neuringer I; El-Khatib FH; Damiano ER; Russell SJ; Putman MS
    Diabetes Care; 2024 Jan; 47(1):101-108. PubMed ID: 37874987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes.
    Haidar A; Legault L; Raffray M; Gouchie-Provencher N; Jafar A; Devaux M; Ghanbari M; Rabasa-Lhoret R
    Diabetes Care; 2023 Jul; 46(7):1372-1378. PubMed ID: 37134305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility Studies of an Insulin-Only Bionic Pancreas in a Home-Use Setting.
    Ekhlaspour L; Nally LM; El-Khatib FH; Ly TT; Clinton P; Frank E; Tanenbaum ML; Hanes SJ; Selagamsetty RR; Hood K; Damiano ER; Buckingham BA
    J Diabetes Sci Technol; 2019 Nov; 13(6):1001-1007. PubMed ID: 31470740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting.
    Castellanos LE; Balliro CA; Sherwood JS; Jafri R; Hillard MA; Greaux E; Selagamsetty R; Zheng H; El-Khatib FH; Damiano ER; Russell SJ
    Diabetes Care; 2021 Jun; 44(6):e118-e120. PubMed ID: 33906916
    [No Abstract]   [Full Text] [Related]  

  • 14. Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial.
    Haidar A; Yale JF; Lovblom LE; Cardinez N; Orszag A; Falappa CM; Gouchie-Provencher N; Tsoukas MA; El Fathi A; Rene J; Eldelekli D; Lanctôt SO; Scarr D; Perkins BA
    Diabetes Obes Metab; 2021 Jun; 23(6):1272-1281. PubMed ID: 33528904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes.
    El-Khatib FH; Russell SJ; Magyar KL; Sinha M; McKeon K; Nathan DM; Damiano ER
    J Clin Endocrinol Metab; 2014 May; 99(5):1701-11. PubMed ID: 24483160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial.
    Tsoukas MA; Majdpour D; Yale JF; Fathi AE; Garfield N; Rutkowski J; Rene J; Legault L; Haidar A
    Lancet Digit Health; 2021 Nov; 3(11):e723-e732. PubMed ID: 34580055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial Impact of the Insulin-Only iLet Bionic Pancreas for Adults, Youth, and Caregivers of Youth with Type 1 Diabetes.
    Weissberg-Benchell J; Vesco AT; Shapiro J; Calhoun P; Damiano ER; Russell SJ; Li Z; El-Khatib FH; Ruedy KJ; Balliro CA; Beck RW
    Diabetes Technol Ther; 2023 Oct; 25(10):705-717. PubMed ID: 37523175
    [No Abstract]   [Full Text] [Related]  

  • 18. A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72.
    Beck RW; Kanapka LG; Breton MD; Brown SA; Wadwa RP; Buckingham BA; Kollman C; Kovatchev B
    Diabetes Technol Ther; 2023 May; 25(5):329-342. PubMed ID: 37067353
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the technical reliability and insulin dosing of a "do-it-yourself artificial pancreas" with a commercial hybrid closed-loop system in a "shadow-mode" scenario: An exploratory study.
    Künzler J; Züger T; Stettler C; Laimer MW; Melmer A
    Diabetes Obes Metab; 2023 Sep; 25(9):2780-2783. PubMed ID: 37311723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.